Global Vaccine Adjuvants Supply, Demand and Key Producers, 2024-2030

Description

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

The global Vaccine Adjuvants market size is expected to reach $ 1144 million by 2030, rising at a market growth of 8.5% CAGR during the forecast period (2024-2030).

The vaccine adjuvants market is driven by the increasing need for more effective and long-lasting vaccines. Adjuvants are substances added to vaccines to enhance the body’s immune response, making vaccines more effective, especially in cases where the antigen alone may not provide sufficient protection. The growing prevalence of infectious diseases and the rising demand for vaccines to address new and emerging pathogens, such as COVID-19 variants, are fueling the development and adoption of advanced adjuvants. Additionally, ongoing research and development in immunology and biotechnology are leading to the creation of novel adjuvants that improve vaccine efficacy and safety.

One of the main challenges in the vaccine adjuvants market is the complexity and cost associated with developing and producing new adjuvants. The process requires significant investment in research and development, as well as rigorous testing to ensure safety and effectiveness. Additionally, there are regulatory hurdles that must be overcome, as new adjuvants need to meet stringent guidelines before they can be approved for use. Public concerns about vaccine safety and the potential for adverse reactions to adjuvants also pose challenges, as any negative perceptions can impact vaccine acceptance and adoption.

This report studies the global Vaccine Adjuvants production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Vaccine Adjuvants and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaccine Adjuvants that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Vaccine Adjuvants total production and demand, 2019-2030, (MT)
Global Vaccine Adjuvants total production value, 2019-2030, (USD Million)
Global Vaccine Adjuvants production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (MT), (based on production site)
Global Vaccine Adjuvants consumption by region & country, CAGR, 2019-2030 & (MT)
U.S. VS China: Vaccine Adjuvants domestic production, consumption, key domestic manufacturers and share
Global Vaccine Adjuvants production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (MT)
Global Vaccine Adjuvants production by Type, production, value, CAGR, 2019-2030, (USD Million) & (MT)
Global Vaccine Adjuvants production by Application, production, value, CAGR, 2019-2030, (USD Million) & (MT)
This report profiles key players in the global Vaccine Adjuvants market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, Escon, Huanuotai Biological, Rico Bio, SDA BIO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaccine Adjuvants market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (USD/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Vaccine Adjuvants Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Vaccine Adjuvants Market, Segmentation by Type:
    Emulsion Adjuvants
    Mineral Adjuvants
    Others

Global Vaccine Adjuvants Market, Segmentation by Application:
    Human Vaccine
    Veterinary Vaccine

Companies Profiled:
    GSK
    CSL Limited
    Croda
    SEPPIC
    Sanofi
    Zhifei Biological
    Escon
    Huanuotai Biological
    Rico Bio
    SDA BIO
    SPI Pharma
    Phibro Animal Health
    Vertellus

Key Questions Answered:
1. How big is the global Vaccine Adjuvants market?
2. What is the demand of the global Vaccine Adjuvants market?
3. What is the year over year growth of the global Vaccine Adjuvants market?
4. What is the production and production value of the global Vaccine Adjuvants market?
5. Who are the key producers in the global Vaccine Adjuvants market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Vaccine Adjuvants Introduction
    1.2 World Vaccine Adjuvants Supply & Forecast
        1.2.1 World Vaccine Adjuvants Production Value (2019 & 2023 & 2030)
        1.2.2 World Vaccine Adjuvants Production (2019-2030)
        1.2.3 World Vaccine Adjuvants Pricing Trends (2019-2030)
    1.3 World Vaccine Adjuvants Production by Region (Based on Production Site)
        1.3.1 World Vaccine Adjuvants Production Value by Region (2019-2030)
        1.3.2 World Vaccine Adjuvants Production by Region (2019-2030)
        1.3.3 World Vaccine Adjuvants Average Price by Region (2019-2030)
        1.3.4 North America Vaccine Adjuvants Production (2019-2030)
        1.3.5 Europe Vaccine Adjuvants Production (2019-2030)
        1.3.6 China Vaccine Adjuvants Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Vaccine Adjuvants Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Vaccine Adjuvants Major Market Trends

2 Demand Summary
    2.1 World Vaccine Adjuvants Demand (2019-2030)
    2.2 World Vaccine Adjuvants Consumption by Region
        2.2.1 World Vaccine Adjuvants Consumption by Region (2019-2024)
        2.2.2 World Vaccine Adjuvants Consumption Forecast by Region (2025-2030)
    2.3 United States Vaccine Adjuvants Consumption (2019-2030)
    2.4 China Vaccine Adjuvants Consumption (2019-2030)
    2.5 Europe Vaccine Adjuvants Consumption (2019-2030)
    2.6 Japan Vaccine Adjuvants Consumption (2019-2030)
    2.7 South Korea Vaccine Adjuvants Consumption (2019-2030)
    2.8 ASEAN Vaccine Adjuvants Consumption (2019-2030)
    2.9 India Vaccine Adjuvants Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Vaccine Adjuvants Production Value by Manufacturer (2019-2024)
    3.2 World Vaccine Adjuvants Production by Manufacturer (2019-2024)
    3.3 World Vaccine Adjuvants Average Price by Manufacturer (2019-2024)
    3.4 Vaccine Adjuvants Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Vaccine Adjuvants Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Vaccine Adjuvants in 2023
        3.5.3 Global Concentration Ratios (CR8) for Vaccine Adjuvants in 2023
    3.6 Vaccine Adjuvants Market: Overall Company Footprint Analysis
        3.6.1 Vaccine Adjuvants Market: Region Footprint
        3.6.2 Vaccine Adjuvants Market: Company Product Type Footprint
        3.6.3 Vaccine Adjuvants Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Vaccine Adjuvants Production Value Comparison
        4.1.1 United States VS China: Vaccine Adjuvants Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Vaccine Adjuvants Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Vaccine Adjuvants Production Comparison
        4.2.1 United States VS China: Vaccine Adjuvants Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Vaccine Adjuvants Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Vaccine Adjuvants Consumption Comparison
        4.3.1 United States VS China: Vaccine Adjuvants Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Vaccine Adjuvants Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Vaccine Adjuvants Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Vaccine Adjuvants Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Vaccine Adjuvants Production (2019-2024)
    4.5 China Based Vaccine Adjuvants Manufacturers and Market Share
        4.5.1 China Based Vaccine Adjuvants Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Vaccine Adjuvants Production Value (2019-2024)
        4.5.3 China Based Manufacturers Vaccine Adjuvants Production (2019-2024)
    4.6 Rest of World Based Vaccine Adjuvants Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Vaccine Adjuvants Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Vaccine Adjuvants Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Vaccine Adjuvants Production (2019-2024)

5 Market Analysis by Type
    5.1 World Vaccine Adjuvants Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Emulsion Adjuvants
        5.2.2 Mineral Adjuvants
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Vaccine Adjuvants Production by Type (2019-2030)
        5.3.2 World Vaccine Adjuvants Production Value by Type (2019-2030)
        5.3.3 World Vaccine Adjuvants Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Vaccine Adjuvants Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Human Vaccine
        6.2.2 Veterinary Vaccine
    6.3 Market Segment by Application
        6.3.1 World Vaccine Adjuvants Production by Application (2019-2030)
        6.3.2 World Vaccine Adjuvants Production Value by Application (2019-2030)
        6.3.3 World Vaccine Adjuvants Average Price by Application (2019-2030)

7 Company Profiles
    7.1 GSK
        7.1.1 GSK Details
        7.1.2 GSK Major Business
        7.1.3 GSK Vaccine Adjuvants Product and Services
        7.1.4 GSK Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 GSK Recent Developments/Updates
        7.1.6 GSK Competitive Strengths & Weaknesses
    7.2 CSL Limited
        7.2.1 CSL Limited Details
        7.2.2 CSL Limited Major Business
        7.2.3 CSL Limited Vaccine Adjuvants Product and Services
        7.2.4 CSL Limited Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 CSL Limited Recent Developments/Updates
        7.2.6 CSL Limited Competitive Strengths & Weaknesses
    7.3 Croda
        7.3.1 Croda Details
        7.3.2 Croda Major Business
        7.3.3 Croda Vaccine Adjuvants Product and Services
        7.3.4 Croda Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Croda Recent Developments/Updates
        7.3.6 Croda Competitive Strengths & Weaknesses
    7.4 SEPPIC
        7.4.1 SEPPIC Details
        7.4.2 SEPPIC Major Business
        7.4.3 SEPPIC Vaccine Adjuvants Product and Services
        7.4.4 SEPPIC Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 SEPPIC Recent Developments/Updates
        7.4.6 SEPPIC Competitive Strengths & Weaknesses
    7.5 Sanofi
        7.5.1 Sanofi Details
        7.5.2 Sanofi Major Business
        7.5.3 Sanofi Vaccine Adjuvants Product and Services
        7.5.4 Sanofi Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Sanofi Recent Developments/Updates
        7.5.6 Sanofi Competitive Strengths & Weaknesses
    7.6 Zhifei Biological
        7.6.1 Zhifei Biological Details
        7.6.2 Zhifei Biological Major Business
        7.6.3 Zhifei Biological Vaccine Adjuvants Product and Services
        7.6.4 Zhifei Biological Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Zhifei Biological Recent Developments/Updates
        7.6.6 Zhifei Biological Competitive Strengths & Weaknesses
    7.7 Escon
        7.7.1 Escon Details
        7.7.2 Escon Major Business
        7.7.3 Escon Vaccine Adjuvants Product and Services
        7.7.4 Escon Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Escon Recent Developments/Updates
        7.7.6 Escon Competitive Strengths & Weaknesses
    7.8 Huanuotai Biological
        7.8.1 Huanuotai Biological Details
        7.8.2 Huanuotai Biological Major Business
        7.8.3 Huanuotai Biological Vaccine Adjuvants Product and Services
        7.8.4 Huanuotai Biological Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Huanuotai Biological Recent Developments/Updates
        7.8.6 Huanuotai Biological Competitive Strengths & Weaknesses
    7.9 Rico Bio
        7.9.1 Rico Bio Details
        7.9.2 Rico Bio Major Business
        7.9.3 Rico Bio Vaccine Adjuvants Product and Services
        7.9.4 Rico Bio Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Rico Bio Recent Developments/Updates
        7.9.6 Rico Bio Competitive Strengths & Weaknesses
    7.10 SDA BIO
        7.10.1 SDA BIO Details
        7.10.2 SDA BIO Major Business
        7.10.3 SDA BIO Vaccine Adjuvants Product and Services
        7.10.4 SDA BIO Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 SDA BIO Recent Developments/Updates
        7.10.6 SDA BIO Competitive Strengths & Weaknesses
    7.11 SPI Pharma
        7.11.1 SPI Pharma Details
        7.11.2 SPI Pharma Major Business
        7.11.3 SPI Pharma Vaccine Adjuvants Product and Services
        7.11.4 SPI Pharma Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 SPI Pharma Recent Developments/Updates
        7.11.6 SPI Pharma Competitive Strengths & Weaknesses
    7.12 Phibro Animal Health
        7.12.1 Phibro Animal Health Details
        7.12.2 Phibro Animal Health Major Business
        7.12.3 Phibro Animal Health Vaccine Adjuvants Product and Services
        7.12.4 Phibro Animal Health Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Phibro Animal Health Recent Developments/Updates
        7.12.6 Phibro Animal Health Competitive Strengths & Weaknesses
    7.13 Vertellus
        7.13.1 Vertellus Details
        7.13.2 Vertellus Major Business
        7.13.3 Vertellus Vaccine Adjuvants Product and Services
        7.13.4 Vertellus Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Vertellus Recent Developments/Updates
        7.13.6 Vertellus Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Vaccine Adjuvants Industry Chain
    8.2 Vaccine Adjuvants Upstream Analysis
        8.2.1 Vaccine Adjuvants Core Raw Materials
        8.2.2 Main Manufacturers of Vaccine Adjuvants Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Vaccine Adjuvants Production Mode
    8.6 Vaccine Adjuvants Procurement Model
    8.7 Vaccine Adjuvants Industry Sales Model and Sales Channels
        8.7.1 Vaccine Adjuvants Sales Model
        8.7.2 Vaccine Adjuvants Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Vaccine Adjuvants Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Vaccine Adjuvants Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Vaccine Adjuvants Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Vaccine Adjuvants Production Value Market Share by Region (2019-2024)
 Table 5. World Vaccine Adjuvants Production Value Market Share by Region (2025-2030)
 Table 6. World Vaccine Adjuvants Production by Region (2019-2024) & (MT)
 Table 7. World Vaccine Adjuvants Production by Region (2025-2030) & (MT)
 Table 8. World Vaccine Adjuvants Production Market Share by Region (2019-2024)
 Table 9. World Vaccine Adjuvants Production Market Share by Region (2025-2030)
 Table 10. World Vaccine Adjuvants Average Price by Region (2019-2024) & (USD/Kg)
 Table 11. World Vaccine Adjuvants Average Price by Region (2025-2030) & (USD/Kg)
 Table 12. Vaccine Adjuvants Major Market Trends
 Table 13. World Vaccine Adjuvants Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (MT)
 Table 14. World Vaccine Adjuvants Consumption by Region (2019-2024) & (MT)
 Table 15. World Vaccine Adjuvants Consumption Forecast by Region (2025-2030) & (MT)
 Table 16. World Vaccine Adjuvants Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Vaccine Adjuvants Producers in 2023
 Table 18. World Vaccine Adjuvants Production by Manufacturer (2019-2024) & (MT)
 Table 19. Production Market Share of Key Vaccine Adjuvants Producers in 2023
 Table 20. World Vaccine Adjuvants Average Price by Manufacturer (2019-2024) & (USD/Kg)
 Table 21. Global Vaccine Adjuvants Company Evaluation Quadrant
 Table 22. World Vaccine Adjuvants Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Vaccine Adjuvants Production Site of Key Manufacturer
 Table 24. Vaccine Adjuvants Market: Company Product Type Footprint
 Table 25. Vaccine Adjuvants Market: Company Product Application Footprint
 Table 26. Vaccine Adjuvants Competitive Factors
 Table 27. Vaccine Adjuvants New Entrant and Capacity Expansion Plans
 Table 28. Vaccine Adjuvants Mergers & Acquisitions Activity
 Table 29. United States VS China Vaccine Adjuvants Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Vaccine Adjuvants Production Comparison, (2019 & 2023 & 2030) & (MT)
 Table 31. United States VS China Vaccine Adjuvants Consumption Comparison, (2019 & 2023 & 2030) & (MT)
 Table 32. United States Based Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Vaccine Adjuvants Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Vaccine Adjuvants Production (2019-2024) & (MT)
 Table 36. United States Based Manufacturers Vaccine Adjuvants Production Market Share (2019-2024)
 Table 37. China Based Vaccine Adjuvants Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Vaccine Adjuvants Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Vaccine Adjuvants Production, (2019-2024) & (MT)
 Table 41. China Based Manufacturers Vaccine Adjuvants Production Market Share (2019-2024)
 Table 42. Rest of World Based Vaccine Adjuvants Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Vaccine Adjuvants Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Vaccine Adjuvants Production, (2019-2024) & (MT)
 Table 46. Rest of World Based Manufacturers Vaccine Adjuvants Production Market Share (2019-2024)
 Table 47. World Vaccine Adjuvants Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Vaccine Adjuvants Production by Type (2019-2024) & (MT)
 Table 49. World Vaccine Adjuvants Production by Type (2025-2030) & (MT)
 Table 50. World Vaccine Adjuvants Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Vaccine Adjuvants Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Vaccine Adjuvants Average Price by Type (2019-2024) & (USD/Kg)
 Table 53. World Vaccine Adjuvants Average Price by Type (2025-2030) & (USD/Kg)
 Table 54. World Vaccine Adjuvants Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Vaccine Adjuvants Production by Application (2019-2024) & (MT)
 Table 56. World Vaccine Adjuvants Production by Application (2025-2030) & (MT)
 Table 57. World Vaccine Adjuvants Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Vaccine Adjuvants Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Vaccine Adjuvants Average Price by Application (2019-2024) & (USD/Kg)
 Table 60. World Vaccine Adjuvants Average Price by Application (2025-2030) & (USD/Kg)
 Table 61. GSK Basic Information, Manufacturing Base and Competitors
 Table 62. GSK Major Business
 Table 63. GSK Vaccine Adjuvants Product and Services
 Table 64. GSK Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. GSK Recent Developments/Updates
 Table 66. GSK Competitive Strengths & Weaknesses
 Table 67. CSL Limited Basic Information, Manufacturing Base and Competitors
 Table 68. CSL Limited Major Business
 Table 69. CSL Limited Vaccine Adjuvants Product and Services
 Table 70. CSL Limited Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. CSL Limited Recent Developments/Updates
 Table 72. CSL Limited Competitive Strengths & Weaknesses
 Table 73. Croda Basic Information, Manufacturing Base and Competitors
 Table 74. Croda Major Business
 Table 75. Croda Vaccine Adjuvants Product and Services
 Table 76. Croda Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Croda Recent Developments/Updates
 Table 78. Croda Competitive Strengths & Weaknesses
 Table 79. SEPPIC Basic Information, Manufacturing Base and Competitors
 Table 80. SEPPIC Major Business
 Table 81. SEPPIC Vaccine Adjuvants Product and Services
 Table 82. SEPPIC Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. SEPPIC Recent Developments/Updates
 Table 84. SEPPIC Competitive Strengths & Weaknesses
 Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 86. Sanofi Major Business
 Table 87. Sanofi Vaccine Adjuvants Product and Services
 Table 88. Sanofi Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Sanofi Recent Developments/Updates
 Table 90. Sanofi Competitive Strengths & Weaknesses
 Table 91. Zhifei Biological Basic Information, Manufacturing Base and Competitors
 Table 92. Zhifei Biological Major Business
 Table 93. Zhifei Biological Vaccine Adjuvants Product and Services
 Table 94. Zhifei Biological Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Zhifei Biological Recent Developments/Updates
 Table 96. Zhifei Biological Competitive Strengths & Weaknesses
 Table 97. Escon Basic Information, Manufacturing Base and Competitors
 Table 98. Escon Major Business
 Table 99. Escon Vaccine Adjuvants Product and Services
 Table 100. Escon Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Escon Recent Developments/Updates
 Table 102. Escon Competitive Strengths & Weaknesses
 Table 103. Huanuotai Biological Basic Information, Manufacturing Base and Competitors
 Table 104. Huanuotai Biological Major Business
 Table 105. Huanuotai Biological Vaccine Adjuvants Product and Services
 Table 106. Huanuotai Biological Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Huanuotai Biological Recent Developments/Updates
 Table 108. Huanuotai Biological Competitive Strengths & Weaknesses
 Table 109. Rico Bio Basic Information, Manufacturing Base and Competitors
 Table 110. Rico Bio Major Business
 Table 111. Rico Bio Vaccine Adjuvants Product and Services
 Table 112. Rico Bio Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Rico Bio Recent Developments/Updates
 Table 114. Rico Bio Competitive Strengths & Weaknesses
 Table 115. SDA BIO Basic Information, Manufacturing Base and Competitors
 Table 116. SDA BIO Major Business
 Table 117. SDA BIO Vaccine Adjuvants Product and Services
 Table 118. SDA BIO Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. SDA BIO Recent Developments/Updates
 Table 120. SDA BIO Competitive Strengths & Weaknesses
 Table 121. SPI Pharma Basic Information, Manufacturing Base and Competitors
 Table 122. SPI Pharma Major Business
 Table 123. SPI Pharma Vaccine Adjuvants Product and Services
 Table 124. SPI Pharma Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. SPI Pharma Recent Developments/Updates
 Table 126. SPI Pharma Competitive Strengths & Weaknesses
 Table 127. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
 Table 128. Phibro Animal Health Major Business
 Table 129. Phibro Animal Health Vaccine Adjuvants Product and Services
 Table 130. Phibro Animal Health Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Phibro Animal Health Recent Developments/Updates
 Table 132. Phibro Animal Health Competitive Strengths & Weaknesses
 Table 133. Vertellus Basic Information, Manufacturing Base and Competitors
 Table 134. Vertellus Major Business
 Table 135. Vertellus Vaccine Adjuvants Product and Services
 Table 136. Vertellus Vaccine Adjuvants Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. Vertellus Recent Developments/Updates
 Table 138. Vertellus Competitive Strengths & Weaknesses
 Table 139. Global Key Players of Vaccine Adjuvants Upstream (Raw Materials)
 Table 140. Global Vaccine Adjuvants Typical Customers
 Table 141. Vaccine Adjuvants Typical Distributors


List of Figures
 Figure 1. Vaccine Adjuvants Picture
 Figure 2. World Vaccine Adjuvants Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Vaccine Adjuvants Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Vaccine Adjuvants Production (2019-2030) & (MT)
 Figure 5. World Vaccine Adjuvants Average Price (2019-2030) & (USD/Kg)
 Figure 6. World Vaccine Adjuvants Production Value Market Share by Region (2019-2030)
 Figure 7. World Vaccine Adjuvants Production Market Share by Region (2019-2030)
 Figure 8. North America Vaccine Adjuvants Production (2019-2030) & (MT)
 Figure 9. Europe Vaccine Adjuvants Production (2019-2030) & (MT)
 Figure 10. China Vaccine Adjuvants Production (2019-2030) & (MT)
 Figure 11. Vaccine Adjuvants Market Drivers
 Figure 12. Factors Affecting Demand
 Figure 13. World Vaccine Adjuvants Consumption (2019-2030) & (MT)
 Figure 14. World Vaccine Adjuvants Consumption Market Share by Region (2019-2030)
 Figure 15. United States Vaccine Adjuvants Consumption (2019-2030) & (MT)
 Figure 16. China Vaccine Adjuvants Consumption (2019-2030) & (MT)
 Figure 17. Europe Vaccine Adjuvants Consumption (2019-2030) & (MT)
 Figure 18. Japan Vaccine Adjuvants Consumption (2019-2030) & (MT)
 Figure 19. South Korea Vaccine Adjuvants Consumption (2019-2030) & (MT)
 Figure 20. ASEAN Vaccine Adjuvants Consumption (2019-2030) & (MT)
 Figure 21. India Vaccine Adjuvants Consumption (2019-2030) & (MT)
 Figure 22. Producer Shipments of Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 23. Global Four-firm Concentration Ratios (CR4) for Vaccine Adjuvants Markets in 2023
 Figure 24. Global Four-firm Concentration Ratios (CR8) for Vaccine Adjuvants Markets in 2023
 Figure 25. United States VS China: Vaccine Adjuvants Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 26. United States VS China: Vaccine Adjuvants Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Vaccine Adjuvants Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States Based Manufacturers Vaccine Adjuvants Production Market Share 2023
 Figure 29. China Based Manufacturers Vaccine Adjuvants Production Market Share 2023
 Figure 30. Rest of World Based Manufacturers Vaccine Adjuvants Production Market Share 2023
 Figure 31. World Vaccine Adjuvants Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 32. World Vaccine Adjuvants Production Value Market Share by Type in 2023
 Figure 33. Emulsion Adjuvants
 Figure 34. Mineral Adjuvants
 Figure 35. Others
 Figure 36. World Vaccine Adjuvants Production Market Share by Type (2019-2030)
 Figure 37. World Vaccine Adjuvants Production Value Market Share by Type (2019-2030)
 Figure 38. World Vaccine Adjuvants Average Price by Type (2019-2030) & (USD/Kg)
 Figure 39. World Vaccine Adjuvants Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 40. World Vaccine Adjuvants Production Value Market Share by Application in 2023
 Figure 41. Human Vaccine
 Figure 42. Veterinary Vaccine
 Figure 43. World Vaccine Adjuvants Production Market Share by Application (2019-2030)
 Figure 44. World Vaccine Adjuvants Production Value Market Share by Application (2019-2030)
 Figure 45. World Vaccine Adjuvants Average Price by Application (2019-2030) & (USD/Kg)
 Figure 46. Vaccine Adjuvants Industry Chain
 Figure 47. Vaccine Adjuvants Procurement Model
 Figure 48. Vaccine Adjuvants Sales Model
 Figure 49. Vaccine Adjuvants Sales Channels, Direct Sales, and Distribution
 Figure 50. Methodology
 Figure 51. Research Process and Data Source

Companies Mentioned

GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio
SDA BIO
SPI Pharma
Phibro Animal Health
Vertellus